EUVIMEDEUVIMED entdecken
CrossrefInfokarte

EARLY PREDICTIVE VALUE OF PERIPHERAL INFLAMMATORY INDEX COMBINED WITH HIGH-SENSITIVITY TROPONIN T FOR SEPSIS-INDUCED CARDIOMYOPATHY

ChunYan Zong, FeiFeng Wu, FenFen Chen, JiaoJiao Yang, Hong Zhou, BaoFeng Zhu

Mediterranean Journal of Hematology and Infectious Diseases · 2026-04-30 · 18 (1) · e2026045

DOI: 10.4084/mjhid.2026.045 ↗
AbstractBibliografische Angaben

Abstract

Background: Sepsis-induced cardiomyopathy (SICM) is a common and critical complication of sepsis, posing significant challenges for early identification. Inflammatory and immune markers may provide complementary information regarding myocardial injury biomarkers. Methods: Of 319 patients firstly diagnosed as sepsis between June 2022 and January 2025 were enrolled. Complete blood counts and high-sensitivity cardiac troponin T (hs-cTnT) were collected within 0–6 hours after diagnosis. SICM was determined based on clinical and imaging data. The peripheral blood inflammatory indices (PBII) was calculated from blood counts, including NLR, SII, SIRI, PLR, and PIV. Variable robustness was assessed using LASSO logistic regression combined with bootstrap resampling. Univariate and multivariate logistic regression analyses were then performed to construct predictive models, with model performance evaluated via ROC curves, calibration curves, and decision curves. Results: This study involved 319 patients with sepsis, among whom 115 (36.1%) developed SICM. Compared with non-SICM patients, SICM patients exhibited significantly elevated high-sensitivity troponin T levels, indicating more pronounced myocardial injury. Peripheral inflammatory indices were also elevated overall, with the most significant differences observed in SII and NLR. SIRI and PLR were also notably elevated, while PIV showed limited variation (all P

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →